Find your path to Elizabeth
1,625 people in our graph share verified history with Elizabeth — schools, employers, funds. One of them is your warm intro.
About
Elizabeth Holt is Chief Business Officer at iOnctura. She was part of the founding team at Aiolos Bio, where she helped negotiate a licensing deal with Jiangsu Hengrui Pharmaceuticals and supported the company's $245M Series A financing prior to its acquisition by GSK in February 2024; earlier, she served as VP, Head of Corporate Planning & Operations at Gyroscope Therapeutics, which Novartis acquired in February 2022, and worked as an Associate Partner at McKinsey & Company advising on strategy, organization, and M&A in life sciences and healthcare. She holds an MBA from NYU Stern School of Business, an MSc from the London School of Economics, and a BA from Davidson College.
CBO at iOnctura
Intro paths
In turn, Elizabeth can intro founders to iOnctura's investors below.
iOnctura's investors · 6
Co-founders at iOnctura


Experience
- iOncturaChief Business Officercurrent2025 — present
- Aiolos BioCo-Founder and VP, of Corporate Strategy & Operations2023 — 2024Greater London, England, United Kingdom
- Tier One BioVP, Corporate Strategy & Operations2022 — 2023Greater London, England, United Kingdom
- Gyroscope TherapeuticsVP, Head of Corporate Planning and Operations2020 — 2022
- Gyroscope TherapeuticsChief of Staff to the CEO2019 — 2020London Area, United Kingdom
- McKinsey & CompanyAssociate Partner2016 — 2019London Area, United Kingdom
- McKinsey & CompanyEngagement Manager2014 — 2016London Area, United Kingdom
- McKinsey & CompanyAssociate2010 — 2014
- Overseas Private Investment CorporationIntern, SME2009
- DAIContracts Administrator2007 — 2008
- DAI- Bosnia and HerzegovinaOperations Manager2007
- DAIGrants Manager- Macedonia2006 — 2007
- DAIProject Associate2004 — 2006
- Greater Washington Board of TradeProgram Assistant, International Gateway2001 — 2002
Skills & more
From Elizabeth's professional profile.
Frequently asked questions
- Who is Elizabeth Holt?
- Elizabeth Holt is Chief Business Officer at iOnctura. She was part of the founding team at Aiolos Bio, where she helped negotiate a licensing deal with Jiangsu Hengrui Pharmaceuticals and supported the company's $245M Series A financing prior to its acquisition by GSK in February 2024; earlier, she served as VP, Head of Corporate Planning & Operations at Gyroscope Therapeutics, which Novartis acquired in February 2022, and worked as an Associate Partner at McKinsey & Company advising on strategy, organization, and M&A in life sciences and healthcare. She holds an MBA from NYU Stern School of Business, an MSc from the London School of Economics, and a BA from Davidson College.
- Where does Elizabeth Holt work?
- Elizabeth Holt is CBO at iOnctura.
- Where did Elizabeth Holt go to school?
- Elizabeth Holt studied at NYU Stern School of Business (MBA); The London School of Economics and Political Science (LSE) (MSc, Development Studies); Davidson College (BA).
Same school
Also attended NYU Stern School of Business822
+ 816 more
Also attended The London School of Economics and Political Science (LSE)1,646
+ 1,640 more
Also attended Davidson College92
+ 86 more
Shared employers
Also worked at iOnctura12
+ 6 more
Also worked at Aiolos Bio4
Also worked at Gyroscope Therapeutics5
Also worked at McKinsey & Company2,000
+ 1,994 more











































